News from the American College of Gastroenterology (ACG)
New Evidence Reveals Impact of Fecal Transplantation upon Gut Flora and Digestive Health
Among Immune Compromised Patients and Those with Chronic GI Disorders: IBD, IBS
Fecal Microbiota Transplant effective at resolving C. diff. infections.
Direct quote from Dr. Colleen Kelly, MD, FACG of Brown University:
“Fecal microbiota transplantation appears effective for the treatment of C. difficile infection, though there is concern that immunocompromised patients may be at increased risk of having adverse events related to FMT,” explained Dr. Kelly.
For the entire article in its’ entirety please click on the link below.